ADQ’s acquisition of Amoun Pharmaceutical’s operations in Egypt for USD 740 million

Lead party: ADQ (lead investor/buyer)Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed). Target: Amoun Pharmaceutical Company S.A.E. (private company) · Sector: Healthcare, Pharmaceuticals · Countries of operation: Egypt Transaction type: Merger/Acquisition(M&A), Exit · Asset class: Corporate Transactions · Deal amount: US$740m · Equity stake: 1% · Implied EV: US$740m Lead…


Lead party: ADQ (lead investor/buyer)

Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed).

Target: Amoun Pharmaceutical Company S.A.E. (private company) · Sector: Healthcare, Pharmaceuticals · Countries of operation: Egypt

Transaction type: Merger/Acquisition(M&A), Exit · Asset class: Corporate Transactions · Deal amount: US$740m · Equity stake: 1% · Implied EV: US$740m

Lead investor/buyer: ADQ · Investors/buyers: ADQ · Sellers: Bausch Health Companies Inc., Undisclosed Investors

Legal advisers: not identified in the source record.

Source: announced 31 March 2021. Original announcement: adq.ae.